RE:RE:New Press Release - Theralase(R) Announces Appointment of New Independent DirectorCetainly appears to be a great addition to our Board. However, Hepion is a trainwreck; used to be called Contravir and management, many of whom still sit on their Board, ran the thing into the ground and destroyed shareholder value. Hopefully she can help our Board avoid the same pitfalls.